ABSORPTION, TISSUE DISTRIBUTION, AND EXCRETION OF TRITIUM-LABELED IVERMECTIN IN CATTLE, SHEEP, AND RAT

被引:107
作者
CHIU, SHL
GREEN, ML
BAYLIS, FP
ELINE, D
ROSEGAY, A
MERIWETHER, H
JACOB, TA
机构
[1] Department of Animal and Exploratory Drug Metabolism, Merck Sharp and Dohme Research Laboratories, New Jersey 07065, P.O. Box 2000, Rahway
关键词
D O I
10.1021/jf00101a015
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Tritium-labeled ivermectin was studied in cattle, sheep, and rat for absorption, tissue residue distribution, and excretion at doses of 0.3 mg/kg of body weight. The drug was absorbed by various dosing routes. By intraruminal and subcutaneous dosing routes, highest tissue residues were present in fat and liver of cattle, with half-lives of 6-8 and 4-5 days, respectively. Shorter half-lives (1-2 days) were observed in sheep and rat. The tissue residue distribution pattern was essentially the same for all species studied and similar in male and female rats. With doses of tritium-labeled avermectin B1aranging from 0.06 to 7.5 mg/kg of body weight, plasma and tissue residue concentrations increased proportionally with the dose. When ivermectin was administered by various routes (ip, sc, iv, oral, and intraruminal), blood residue levels converged to 20-50 ppb 4 h after dosing and then depleted at a similar rate regardless of the dosing route. Ivermectin was excreted primarily in the feces, with only less than 2% of the doses being eliminated in the urine in all three species studied. © 1990, American Chemical Society. All rights reserved.
引用
收藏
页码:2072 / 2078
页数:7
相关论文
共 20 条
  • [11] AVERMECTINS, NEW FAMILY OF POTENT ANTHELMINTIC AGENTS - EFFICACY OF THE B1A COMPONENT
    EGERTON, JR
    OSTLIND, DA
    BLAIR, LS
    EARY, CH
    SUHAYDA, D
    CIFELLI, S
    RIEK, RF
    CAMPBELL, WC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 15 (03) : 372 - 378
  • [12] FINK DW, 1989, PHARMACOKINETICS IVE
  • [13] HALLEY BA, 1989, IVERMECTIN ABAMECTIN
  • [14] JACOB TA, 1983, 22 P MSD AGVET S REC
  • [15] LO PKA, 1985, VET RES COMMUN, V9, P251
  • [16] FATE OF AVERMECTIN B-1A IN RATS
    MAYNARD, MS
    HALLEY, BA
    GREENERWIN, M
    ALVARO, R
    GRUBER, VF
    HWANG, SC
    BENNETT, BW
    WISLOCKI, PG
    [J]. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1990, 38 (03) : 864 - 870
  • [17] AVERMECTINS, NEW FAMILY OF POTENT ANTHELMINTIC AGENTS - ISOLATION AND CHROMATOGRAPHIC PROPERTIES
    MILLER, TW
    CHAIET, L
    COLE, DJ
    COLE, LJ
    FLOR, JE
    GOEGELMAN, RT
    GULLO, VP
    JOSHUA, H
    KEMPF, AJ
    KRELLWITZ, WR
    MONAGHAN, RL
    ORMOND, RE
    WILSON, KE
    ALBERSSCHONBERG, G
    PUTTER, I
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 15 (03) : 368 - 371
  • [18] MIWA GT, 1982, DRUG METAB DISPOS, V10, P268
  • [19] PHARMACOKINETICS OF IVERMECTIN IN SHEEP FOLLOWING INTRAVENOUS, INTRA-ABOMASAL OR INTRARUMINAL ADMINISTRATION
    PRICHARD, RK
    STEEL, JW
    LACEY, E
    HENNESSY, DR
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1985, 8 (01) : 88 - 94
  • [20] PHARMACOKINETICS OF IVERMECTIN ADMINISTERED INTRAVENOUSLY TO CATTLE
    WILKINSON, PK
    POPE, DG
    BAYLIS, FP
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (10) : 1105 - 1107